Are drugs too expensive in Canada?

被引：0

作者：

Lexchin, J

Williams, R

Marion, J

机构：

[1] York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada

[2] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada

来源：

CANADIAN FAMILY PHYSICIAN | 2006年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：573 / 576

页数：4

共 10 条

[1]

[Anonymous], 2004, PHARM PRIC CONTR OEC

[2] The price of innovation: new estimates of drug development costs [J].

DiMasi, JA ;

Hansen, RW ;

Grabowski, HG .

JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) :151-185

[3] COST OF INNOVATION IN THE PHARMACEUTICAL-INDUSTRY [J].

DIMASI, JA ;

HANSEN, RW ;

GRABOWSKI, HG ;

LASAGNA, L .

JOURNAL OF HEALTH ECONOMICS, 1991, 10 (02) :107-142

[4] Returns on research and development for 1990s new drug introductions [J].

Grabowski, H ;

Vernon, J ;

DiMasi, JA .

PHARMACOECONOMICS, 2002, 20 (Suppl 3) :11-29

[5] Extraordinary claims require extraordinary evidence [J].

Light, DW ;

Warburton, RN .

JOURNAL OF HEALTH ECONOMICS, 2005, 24 (05) :1030-1033

[6]

*PAT MED PRIC REV, 2005, PMRPB ANN REP 2004

[7]

*PRESCR INT, 2004, PRESCR INT, V13, P71

[8]

*STAT CAN, 1996, 61F0058XPE STAT CAN

[9]

*US FDA, 2005, CDER NDAS APPROVED C

[10]

*WHO, 2003, DRUG PROM DAT IMP DO

← 1 →